<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(4)</volume><submitter>Cipriani A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Low QRS voltages (LQRSVs) are a common electrocardiographic feature in patients with light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) cardiac amyloidosis (CA).&lt;h4>Objectives&lt;/h4>The aim of this study was to identify clinical and echocardiographic correlates of LQRSV and to investigate their prognostic significance in patients with CA.&lt;h4>Methods&lt;/h4>This was a multicenter, retrospective study performed in 6 CA referral centers including consecutive patients with AL and ATTR CA. LQRSVs were defined as a QRS amplitude ≤5 mm (0.5 mV) in all peripheral leads. The study outcome was cardiovascular (CV) mortality.&lt;h4>Results&lt;/h4>Overall, 411 (AL CA: n = 120, ATTR CA: n = 291) patients were included. LQRSVs were present in 66 (55%) patients with AL CA and 103 (3</pubmed_abstract><journal>JACC. CardioOncology</journal><pagination>458-470</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9700257</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.</pubmed_title><pmcid>PMC9700257</pmcid><pubmed_authors>Russo D</pubmed_authors><pubmed_authors>Sessarego E</pubmed_authors><pubmed_authors>Rapezzi C</pubmed_authors><pubmed_authors>Autore C</pubmed_authors><pubmed_authors>Licchelli L</pubmed_authors><pubmed_authors>Fumagalli C</pubmed_authors><pubmed_authors>Gregori D</pubmed_authors><pubmed_authors>Di Bella G</pubmed_authors><pubmed_authors>Perazzolo Marra M</pubmed_authors><pubmed_authors>Zampieri M</pubmed_authors><pubmed_authors>Argiro A</pubmed_authors><pubmed_authors>Tini G</pubmed_authors><pubmed_authors>Cappelli F</pubmed_authors><pubmed_authors>De Michieli L</pubmed_authors><pubmed_authors>Sinagra G</pubmed_authors><pubmed_authors>Porcari A</pubmed_authors><pubmed_authors>Canepa M</pubmed_authors><pubmed_authors>Iliceto S</pubmed_authors><pubmed_authors>Sinigiani G</pubmed_authors><pubmed_authors>De Gaspari M</pubmed_authors><pubmed_authors>Musumeci B</pubmed_authors><pubmed_authors>Cipriani A</pubmed_authors><pubmed_authors>Merlo M</pubmed_authors><pubmed_authors>Licordari R</pubmed_authors><pubmed_authors>Perfetto F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.</name><description>&lt;h4>Background&lt;/h4>Low QRS voltages (LQRSVs) are a common electrocardiographic feature in patients with light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) cardiac amyloidosis (CA).&lt;h4>Objectives&lt;/h4>The aim of this study was to identify clinical and echocardiographic correlates of LQRSV and to investigate their prognostic significance in patients with CA.&lt;h4>Methods&lt;/h4>This was a multicenter, retrospective study performed in 6 CA referral centers including consecutive patients with AL and ATTR CA. LQRSVs were defined as a QRS amplitude ≤5 mm (0.5 mV) in all peripheral leads. The study outcome was cardiovascular (CV) mortality.&lt;h4>Results&lt;/h4>Overall, 411 (AL CA: n = 120, ATTR CA: n = 291) patients were included. LQRSVs were present in 66 (55%) patients with AL CA and 103 (3</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T20:48:54.842Z</modification><creation>2025-04-06T08:34:15.433Z</creation></dates><accession>S-EPMC9700257</accession><cross_references><pubmed>36444225</pubmed><doi>10.1016/j.jaccao.2022.08.007</doi></cross_references></HashMap>